India extends medical device PLI scheme to FY2035–36 and invites fresh applications
The Department of Pharmaceuticals has extended the Production Linked Incentive Scheme for Promoting Domestic Manufacturing of Medical Devices (PLI-MD) up to 2035–36 and invited fresh applications. Updated guidelines discontinue the minimum sales threshold for incentives and reduce the minimum investment requirement; an online application portal is expected to be operational within 10 days, with applications across multiple segments including consumables, disposables/implants, critical components and high-end devices.
Extending and loosening eligibility for the PLI-MD scheme can enable more manufacturers to qualify for incentives and invest in domestic production of medical devices and components that India currently imports or only assembles.